Clinical Ototoxicity of Topical Antibiotic Drops

Brown OE Wright CO Meyerhoff WL . Topical agents: Efficacy or treatment in humans. In: Bluestone CD Kenna MD Scheetz MD , eds. Workshop on chronic suppurative otitis media: Etiology and management. Ann Otol Rhinol Laryngol 1988; 97 (suppl 131):38–40.

Morizono T . Ototopical agents: Ototoxicity in animal studies. In: Bluestone CD Kenna MA Scheetz MD , eds. Workshop on chronic suppurative otitis media: Etiology and management. Ann Otol Rhinol Laryngol 1988; 97 (suppl 131)28–30.

Morizono T . Toxicity of ototopical drops: Animal modeling. Ann Otol Rhinol Laryngol 1990; 99: 42–5.

Ikeda K Morizono T . Round window membrane permeability during experimental purulent otitis media: Altered Cortisporin ototoxicity. Ann Otol Rhinol Laryngol 1990; 99: 46–8.

Wright CG Meyerhoff WL . Ototopical Agents: Efficacy or Toxicity in Humans. In Bluestone CD Kenna MA Scheetz MD , eds. Workshop on chronic suppurative otitis media: Etiology and management. Ann Otol Rhinol Laryngol 1988; 97 (suppl 131):30–2.

Sahni RS Paparella MM Schachern PA Goycoolea MV Le CT . Thickness of the human round window membrane in different forms of otitis media. Arch Otolaryngol Head Neck Surg 1987; 113: 630–4.

Goycoolea MV Paparella MM Goldberg B Carpenter AM . Permeability of the round window membrane in otitis media. Arch Otolaryngol Head Neck Surg 1980; 106: 430–3.

Stupp H Kupper K Lagler F Sous H Quante M . Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application. Audiology 1973; 12: 350–63.

Hermansson A Prellner K Hellstrom S . Persistent structural changes in the middle ear mucosa of the rat, after an experimentally induced episode of pneumococcal otitis media. Acta Otolaryngol (Stockh) 1990; 109: 421–30.

Schuknecht HF Gulya AJ . Anatomy of the temporal bone with surgical implications. Philadelphia: Lea & Febiger, 1986.

Meyerhoff WL Morizono T Shaddock LC Wright CG Shea DA Sikora MA . Tympanostomy tubes and otic drops. Laryngoscope 1983; 93: 1022–7.

Kellerhals G . Horschaden durch ototoxische Ohrtropfen. HNO 1978; 26: 49–52.

Paparella MM . Insidious labyrinthine changes in otitis media. Acta Otolaryngol (Stockh) 1981; 92: 513–20.

Nomura Y . Otological significance of the round window. In: Pfoltz CR , ed. Advances in oto-rhino-laryngology. Vol. 33. New York: S. Karger, 1984: 1–164.

Lind O Kristiansen B . Deafness after treatment with ear drops containing neomycin, gramicidin, and dexamethasone. Orl J Otorhinolaryngol Relat Spec 1986; 48: 52–4.

Leliever WC . Topical gentomycin-induced positional vertigo. Otolaryngol Head Neck Surg 1985; 94: 553–5.

Dumas G Bessard G Gavend M Charachon R . Risk of deafness following ototopical administration of aminoglycoside antibiotic [Author's trans]. Therapie 1980; 35: 357–63.

Martin H Martin C . Otoxicity of ear drops. Journal Francais D'Oto-Rhino-Laryngologie 1980; 29: 19–37.

Tommerkup B Moller K . A case of profound hearing impairment following the primary use of Framycetin ear drops. J Laryngol Otol 1984; 98: 1135–7.

Murphy KWR . Deafness after topical neomycin. BMJ April 1970.

Podoshin L Fradis M David JB . Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 1989; 103: 46–50.

Lundy LB Graham MD . Ototoxicity and ototopical medications: A survey of otolaryngologists. Am J Otol 1993; 14: 141–6.

Matsumara H . A case report of anaphylaxis caused by local application of 0.5% Chloromycetin otic solution. Otologia Fukuoka 1964; 10: 48–51.